AU Stock MarketDetailed Quotes

CPHOA Creso Pharma Ltd

Watchlist
  • 0.002
  • 0.0000.00%
20min DelayNot Open Jan 17 16:00 AET
72.88KMarket Cap0.00P/E (Static)

Creso Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2021
(Q4)Dec 30, 2021
(FY)Dec 30, 2020
(Q4)Dec 30, 2020
(FY)Dec 30, 2019
(Q4)Dec 30, 2019
(FY)Dec 30, 2018
(Q4)Dec 30, 2018
Assets
Current assets
Cash, cash equivalents and short term investments
18.81%7.18M
18.81%7.18M
115.94%6.05M
115.94%6.05M
-56.18%2.8M
-56.18%2.8M
--6.39M
--6.39M
-Cash and cash equivalents
18.81%7.18M
18.81%7.18M
115.94%6.05M
115.94%6.05M
-56.18%2.8M
-56.18%2.8M
--6.39M
--6.39M
-Accounts receivable
1,409.04%408.27K
1,409.04%408.27K
-97.34%27.06K
-97.34%27.06K
--1.02M
--1.02M
----
----
-Other receivables
-22.20%1.19M
-22.20%1.19M
41.54%1.53M
41.54%1.53M
-56.85%1.08M
-56.85%1.08M
--2.5M
--2.5M
Total current assets
27.79%10.14M
27.79%10.14M
14.76%7.94M
14.76%7.94M
-16.49%6.92M
-16.49%6.92M
--8.28M
--8.28M
Non current assets
-Accumulated depreciation
-59.39%-1.7M
-59.39%-1.7M
-141.14%-1.07M
-141.14%-1.07M
---442.08K
---442.08K
----
----
-Goodwill
551.19%8.31M
551.19%8.31M
-71.49%1.28M
-71.49%1.28M
9.18%4.48M
9.18%4.48M
--4.1M
--4.1M
Regulatory assets
73.04%1.1M
73.04%1.1M
-62.51%636.72K
-62.51%636.72K
78.58%1.7M
78.58%1.7M
--951.13K
--951.13K
Liabilities
Current liabilities
Current debt and capital lease obligation
----
----
0.88%3.26M
0.88%3.26M
16.24%3.23M
16.24%3.23M
--2.78M
--2.78M
-Current debt
----
----
0.88%3.26M
0.88%3.26M
16.24%3.23M
16.24%3.23M
--2.78M
--2.78M
-accounts payable
-55.58%281.59K
-55.58%281.59K
-38.50%633.92K
-38.50%633.92K
120.62%1.03M
120.62%1.03M
--467.24K
--467.24K
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
-Other payable
--423.19K
--423.19K
----
----
----
----
----
----
Current provisions
----
----
----
----
--51.26K
--51.26K
----
----
Current liabilities
-71.56%1.56M
-71.56%1.56M
1.46%5.47M
1.46%5.47M
-6.72%5.39M
-6.72%5.39M
--5.78M
--5.78M
Non current liabilities
Non current accrued expenses
5.32%10.44M
5.32%10.44M
-12.09%9.91M
-12.09%9.91M
13.84%11.27M
13.84%11.27M
--9.9M
--9.9M
Preferred securities outside stock equity
69.46%84.35K
69.46%84.35K
--49.77K
--49.77K
----
----
--30.95K
--30.95K
Total non current liabilities
-71.56%1.56M
-71.56%1.56M
1.46%5.47M
1.46%5.47M
-6.72%5.39M
-6.72%5.39M
--5.78M
--5.78M
Shareholders'equity
Share capital
53.15%109.95M
53.15%109.95M
54.30%71.79M
54.30%71.79M
21.73%46.53M
21.73%46.53M
--38.22M
--38.22M
-common stock
53.15%109.95M
53.15%109.95M
54.30%71.79M
54.30%71.79M
21.73%46.53M
21.73%46.53M
--38.22M
--38.22M
Gains losses not affecting retained earnings
-47.06%12.63M
-47.06%12.63M
5.56%23.86M
5.56%23.86M
52.73%22.6M
52.73%22.6M
--14.8M
--14.8M
Other equity interest
----
----
----
----
----
----
--495.49K
--495.49K
Total equity
53.31%29.31M
53.31%29.31M
-15.63%19.12M
-15.63%19.12M
1.71%22.66M
1.71%22.66M
--22.28M
--22.28M
(FY)Dec 30, 2021(Q4)Dec 30, 2021(FY)Dec 30, 2020(Q4)Dec 30, 2020(FY)Dec 30, 2019(Q4)Dec 30, 2019(FY)Dec 30, 2018(Q4)Dec 30, 2018
Assets
Current assets
Cash, cash equivalents and short term investments 18.81%7.18M18.81%7.18M115.94%6.05M115.94%6.05M-56.18%2.8M-56.18%2.8M--6.39M--6.39M
-Cash and cash equivalents 18.81%7.18M18.81%7.18M115.94%6.05M115.94%6.05M-56.18%2.8M-56.18%2.8M--6.39M--6.39M
-Accounts receivable 1,409.04%408.27K1,409.04%408.27K-97.34%27.06K-97.34%27.06K--1.02M--1.02M--------
-Other receivables -22.20%1.19M-22.20%1.19M41.54%1.53M41.54%1.53M-56.85%1.08M-56.85%1.08M--2.5M--2.5M
Total current assets 27.79%10.14M27.79%10.14M14.76%7.94M14.76%7.94M-16.49%6.92M-16.49%6.92M--8.28M--8.28M
Non current assets
-Accumulated depreciation -59.39%-1.7M-59.39%-1.7M-141.14%-1.07M-141.14%-1.07M---442.08K---442.08K--------
-Goodwill 551.19%8.31M551.19%8.31M-71.49%1.28M-71.49%1.28M9.18%4.48M9.18%4.48M--4.1M--4.1M
Regulatory assets 73.04%1.1M73.04%1.1M-62.51%636.72K-62.51%636.72K78.58%1.7M78.58%1.7M--951.13K--951.13K
Liabilities
Current liabilities
Current debt and capital lease obligation --------0.88%3.26M0.88%3.26M16.24%3.23M16.24%3.23M--2.78M--2.78M
-Current debt --------0.88%3.26M0.88%3.26M16.24%3.23M16.24%3.23M--2.78M--2.78M
-accounts payable -55.58%281.59K-55.58%281.59K-38.50%633.92K-38.50%633.92K120.62%1.03M120.62%1.03M--467.24K--467.24K
-Total tax payable --0--0--0--0--0--0--0--0
-Other payable --423.19K--423.19K------------------------
Current provisions ------------------51.26K--51.26K--------
Current liabilities -71.56%1.56M-71.56%1.56M1.46%5.47M1.46%5.47M-6.72%5.39M-6.72%5.39M--5.78M--5.78M
Non current liabilities
Non current accrued expenses 5.32%10.44M5.32%10.44M-12.09%9.91M-12.09%9.91M13.84%11.27M13.84%11.27M--9.9M--9.9M
Preferred securities outside stock equity 69.46%84.35K69.46%84.35K--49.77K--49.77K----------30.95K--30.95K
Total non current liabilities -71.56%1.56M-71.56%1.56M1.46%5.47M1.46%5.47M-6.72%5.39M-6.72%5.39M--5.78M--5.78M
Shareholders'equity
Share capital 53.15%109.95M53.15%109.95M54.30%71.79M54.30%71.79M21.73%46.53M21.73%46.53M--38.22M--38.22M
-common stock 53.15%109.95M53.15%109.95M54.30%71.79M54.30%71.79M21.73%46.53M21.73%46.53M--38.22M--38.22M
Gains losses not affecting retained earnings -47.06%12.63M-47.06%12.63M5.56%23.86M5.56%23.86M52.73%22.6M52.73%22.6M--14.8M--14.8M
Other equity interest --------------------------495.49K--495.49K
Total equity 53.31%29.31M53.31%29.31M-15.63%19.12M-15.63%19.12M1.71%22.66M1.71%22.66M--22.28M--22.28M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg